KRAS G12C Inhibitor 44 is a potent and orally bioavailable inhibitor targeting the KRAS G12C mutation. This compound exhibits significant anti-proliferative activity, with IC50 values of 0.016 µM in MIA PaCA-2 cells and 0.028 µM in H358 cells. Additionally, KRAS G12C Inhibitor 44 demonstrates antitumor effects in vivo, making it a valuable tool for cancer research focusing on KRAS-driven malignancies.
KRAS G12C Inhibitor 44 is a potent and orally bioavailable inhibitor targeting the KRAS G12C mutation. This compound exhibits significant anti-proliferative activity, with IC50 values of 0.016 µM in MIA PaCA-2 cells and 0.028 µM in H358 cells. Additionally, KRAS G12C Inhibitor 44 demonstrates antitumor effects in vivo, making it a valuable tool for cancer research focusing on KRAS-driven malignancies.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
